For a nice visualization of the changing funding environment for emerging healthcare companies, check out this this graph of VC deals over the past five quarters.
Early-stage healthcare funding – defined as seed and Series A rounds – accounted for 30 percent of the VC deals done in the first quarter of this year, according to a new analysis by CB insights, which tracks venture capital firms. That percentage has dropped consistently over at least the past five quarters, from 41 percent in Q1 of last year.
To read the full, original article click on this link: 2 charts that show how VCs are bypassing early-stage deals in healthcare | MedCity News
